BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 29410282)

  • 1. Osmotic stress induced toxicity exacerbates Parkinson's associated effects via dysregulation of autophagy in transgenic C. elegans model.
    Jadiya P; Mir SS; Nazir A
    Cell Signal; 2018 May; 45():71-80. PubMed ID: 29410282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Parkinsonian effects of β-amyrin are regulated via LGG-1 involved autophagy pathway in Caenorhabditis elegans.
    Wei CC; Chang CH; Liao VH
    Phytomedicine; 2017 Dec; 36():118-125. PubMed ID: 29157804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Butoxytetrahydrofuran, Isolated from
    Promtang S; Sanguanphun T; Chalorak P; Pe LS; Niamnont N; Sobhon P; Meemon K
    ACS Chem Neurosci; 2024 Jun; 15(11):2182-2197. PubMed ID: 38726817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
    Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
    J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MANF protects dopamine neurons and locomotion defects from a human α-synuclein induced Parkinson's disease model in C. elegans by regulating ER stress and autophagy pathways.
    Zhang Z; Shen Y; Luo H; Zhang F; Peng D; Jing L; Wu Y; Xia X; Song Y; Li W; Jin L
    Exp Neurol; 2018 Oct; 308():59-71. PubMed ID: 29959908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
    Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in
    Chalorak P; Sanguanphun T; Limboonreung T; Meemon K
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity.
    Kim H; Calatayud C; Guha S; Fernández-Carasa I; Berkowitz L; Carballo-Carbajal I; Ezquerra M; Fernández-Santiago R; Kapahi P; Raya Á; Miranda-Vizuete A; Lizcano JM; Vila M; Caldwell KA; Caldwell GA; Consiglio A; Dalfo E
    Mol Neurobiol; 2018 Sep; 55(9):7533-7552. PubMed ID: 29429047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spermidine protects against α-synuclein neurotoxicity.
    Büttner S; Broeskamp F; Sommer C; Markaki M; Habernig L; Alavian-Ghavanini A; Carmona-Gutierrez D; Eisenberg T; Michael E; Kroemer G; Tavernarakis N; Sigrist SJ; Madeo F
    Cell Cycle; 2014; 13(24):3903-8. PubMed ID: 25483063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.
    Bornhorst J; Chakraborty S; Meyer S; Lohren H; Brinkhaus SG; Knight AL; Caldwell KA; Caldwell GA; Karst U; Schwerdtle T; Bowman A; Aschner M
    Metallomics; 2014 Mar; 6(3):476-90. PubMed ID: 24452053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's disease.
    Fu RH; Wang YC; Chen CS; Tsai RT; Liu SP; Chang WL; Lin HL; Lu CH; Wei JR; Wang ZW; Shyu WC; Lin SZ
    Neuropharmacology; 2014 Jul; 82():108-20. PubMed ID: 23973292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferulic Acid Exerts Neuroprotective Effects via Autophagy Induction in
    Long T; Wu Q; Wei J; Tang Y; He YN; He CL; Chen X; Yu L; Yu CL; Law BY; Wu JM; Qin DL; Wu AG; Zhou XG
    Oxid Med Cell Longev; 2022; 2022():3723567. PubMed ID: 35242276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi of cat-2, a putative tyrosine hydroxylase, increases alpha synuclein aggregation and associated effects in transgenic C. elegans.
    Kaur S; Sammi SR; Jadiya P; Nazir A
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):387-94. PubMed ID: 22483307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCEH-1 modulates cholesterol metabolism and protects against α-synuclein toxicity in a C. elegans model of Parkinson's disease.
    Zhang S; Glukhova SA; Caldwell KA; Caldwell GA
    Hum Mol Genet; 2017 Oct; 26(19):3823-3836. PubMed ID: 28934392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.
    Jadiya P; Khan A; Sammi SR; Kaur S; Mir SS; Nazir A
    Biochem Biophys Res Commun; 2011 Oct; 413(4):605-10. PubMed ID: 21925152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diterpene glycosides from Holothuria scabra exert the α-synuclein degradation and neuroprotection against α-synuclein-Mediated neurodegeneration in C. elegans model.
    Chalorak P; Sornkaew N; Manohong P; Niamnont N; Malaiwong N; Limboonreung T; Sobhon P; Aschner M; Meemon K
    J Ethnopharmacol; 2021 Oct; 279():114347. PubMed ID: 34147616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices.
    Youssef K; Tandon A; Rezai P
    Integr Biol (Camb); 2019 May; 11(5):186-207. PubMed ID: 31251339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
    Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
    PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Parkinson Effects of
    Sanguanphun T; Promtang S; Sornkaew N; Niamnont N; Sobhon P; Meemon K
    Mar Drugs; 2023 Feb; 21(3):. PubMed ID: 36976190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.